First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial. - Quintero Aldana G; Salgado M; Candamio S; Méndez JC; Jorge M; Reboredo M; Vázquez Tuñas L; Romero C; Covela M; Fernández Montes A; Carmona M; Vidal Insua Y; et al. (Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020)